Emtricitabine Side Effects
>>>Help Community - Post Your Emtricitabine Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Emtricitabine Side Effects
Emtricitabine Safety Reports submitted to FDA
Total Emtricitabine reports: 113.Emtricitabine FDA safety alerts: No.
Reported deaths: 38 Reported hospitalizations: 72.
Take Emtricitabine Side Effects Survey or Share Your Emtricitabine Story.
Reported Emtricitabine Side Effects: anaemia, death, pregnancy, neutropenia, leukopenia, stevens-johnson syndrome, hepatitis toxic, pulmonary tuberculosis, pancreatitis acute, pyrexia, abdominal pain upper.
More About Emtricitabine.
If you have questions about Emtricitabine, you can ask a Health Expert or Ask Patient Community about Emtricitabine.
Showing 1-100 of 113 Next >
Emtricitabine Side Effects Report #5422895-5Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Aug 13, 2007. Female patient, 27 years of age, weighting 59.52 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary tuberculosis. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE, COTRIM, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Emtricitabine Side Effects Report #5426993-1
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2007. Female patient, 34 years of age, weighting 94.80 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, hiv infection. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA, LOPERAMIDE, MICONAZOLE ORAL GEL, CIPROFOXAN. Patient was hospitalized. Patient died on 07/30/2007.
Emtricitabine Side Effects Report #5439508-9
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Aug 21, 2007. Female patient, 33 years of age, weighting 152.1 lb, was diagnosed with hiv infection, deep vein thrombosis and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis, tubal ligation. EMTRICITABINE dosage: unknown. During the same period patient was treated with KALETRA, ENOXAPARIN, WARFARIN. Patient was hospitalized. Patient recovered.
Emtricitabine Side Effects Report #5440786-0
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. EMTRICITABINE dosage: unknown. During the same period patient was treated with DIDANOSINE, ATAZANAVIR SULPHATE, ATAZANAVIR SULPHATE, ETHAMBUTOL HYDROCHLORIDE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient recovered.
Emtricitabine Side Effects Report #5449026-X
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Sept 06, 2007. Male patient, 29 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. EMTRICITABINE dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, SULFAMETHOXAZOLE AND TRIMETHOTRIM, AZITHROMYCIN. Patient was hospitalized. Patient died on 07/26/2007.
Emtricitabine Side Effects Report #5451579-2
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 34 years of age, weighting 94.80 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: abasia, abdominal pain, anaemia, anorexia, blood albumin decreased, blood potassium decreased, bronchitis, cachexia, confusional state. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, KALETRA, LOPERAMIDE, MICONAZOLE ORAL GEL, CIPROFOXAN. Patient was hospitalized. Patient died on 07/30/2007.
Emtricitabine Side Effects Report #5456403-X
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Sept 11, 2007. Female patient, 40 years of age, weighting 136.1 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, SULFAMETHOXAZOLE AND TRIMETHOPRIM, IRON PREPARATIONS, VITAMIN B CAP. Patient died on 01/08/2007.
Emtricitabine Side Effects Report #5456425-9
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Female patient, 36 years of age, weighting 209.4 lb, was diagnosed with hiv infection, contraception, anaemia, helminthic infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, MICROGYNON, FERROUS SULPHATE, FERROUS SULPHATE, ALBENDAZOLE, VITAMIN CAP, MAGNESIUM SULPHATE. Patient died on 12/30/2006.
Emtricitabine Side Effects Report #5457446-2
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Sept 11, 2007. Male patient, 41 years of age, weighting 129.0 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, ATAZANAVIR SULPHATE, KALETRA, OMEPRAZOLE, CIPROFLOXACIN, PARACETAMOL, BUSCOPAN, FLUCONAZOLE. Patient died on 07/18/2007.
Emtricitabine Side Effects Report #5457447-4
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Male patient, 29 years of age, weighting 143.3 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. EMTRICITABINE dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, SULFAMETHOXAZOLE AND TRIMETHOTRIM, AZITHROMYCIN. Patient was hospitalized. Patient died on 07/26/2007.
Emtricitabine Side Effects Report #5457496-6
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Sept 11, 2007. Female patient, 27 years of age, weighting 59.52 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pulmonary tuberculosis. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, ETHAMBUTOL, COTRIMOXAZOLE, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Emtricitabine Side Effects Report #5464180-1
EMTRICITABINE problem was reported by a Consumer or non-health professional from FRANCE on Sept 11, 2007. Female patient, 20 years of age, weighting 145.5 lb, was diagnosed with human immunodeficiency virus transmission, opportunistic infection prophylaxis, anaemia prophylaxis and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia, pregnancy. EMTRICITABINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, COTRIMOXAZOLE, NEVIRAPINE, AMOXICILLIN, IRON AND FOLIC ACID. Patient recovered.
Emtricitabine Side Effects Report #5467210-6
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Aug 16, 2007. Female patient, 53 years of age, weighting 126.5 lb, was diagnosed with hiv infection and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: paraplegia. EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ENALAPRIL MALEATE, GLIPIZIDE, VITAMINS. Patient was hospitalized. Patient recovered.
Showing 1-100 of 113 Next >
Drug Information: Emtricitabine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a604004.html
(em tri sit' uh bean)IMPORTANT WARNING:
| Medications that are similar to emtricitabine have caused serious damage to the liver and a life-threatening condition called lactic acidosis (buildup of lactic acid in the blood) when they were used alone or in combination with other medications that treat human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). Tell your doctor if you have or have ever had liver disease. If you experience any of the following symptoms, call your doctor immediately: upset stomach; vomiting; stomach pain; loss of appetite; extreme tiredness; weakness; dizziness; light-headedness; fast or irregular heartbeat; trouble breathing; dark yellow or brown urine; light-colored bowel movements; yellowing of the skin or eyes; feeling cold, especially in the arms or legs; or muscle pain that is different than any muscle pain you usually experience.Emtricitabine should not be used to treat hepatitis B virus infection (HBV; an ongoing liver infection). Tell your doctor if you have or think you may have HBV. Your doctor may test you to see if you have HBV before you begin your treatment with emtricitabine. If you have HBV and you take emtricitabine, your condition may suddenly worsen when you stop taking emtricitabine. Your doctor will examine you and order lab tests regularly for several months after you stop taking emtricitabine to see if your HBV has worsened.Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to emtricitabine. Talk to your doctor about the risks of taking emtricitabine. |
Why is this medication prescribed?
Emtricitabine is used with other medications to treat HIV infection in patients with or without AIDS. Emtricitabine is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). This medication works by slowing the spread of HIV in the body. Emtricitabine does not cure HIV infection and may not prevent you from developing HIV-related illnesses. Emtricitabine does not prevent you from spreading HIV to other people.
How should this medicine be used?
Emtricitabine comes as a capsule and a solution (liquid) to take by mouth. It is usually taken once a day with or without food. Take emtricitabine at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take emtricitabine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Emtricitabine controls HIV infection but does not cure it. Continue to take emtricitabine even if you feel well. Do not stop taking emtricitabine without talking to your doctor. When your supply of emtricitabine starts to run low, get more from your doctor or pharmacist. If you miss doses or stop taking emtricitabine, your condition may become more difficult to treat.
Ask your doctor or pharmacist for a copy of the manufacturer's information for the patient.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking emtricitabine,
- tell your doctor and pharmacist if you are allergic to emtricitabine or any other medications.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you more carefully for side effects.
- tell your doctor if you have or have ever had the conditions mentioned in the IMPORTANT WARNING section, any type of infection that does not go away or that comes and goes such as tuberculosis (TB; a type of lung infection) or cytomegalovirus (CMV; a viral infection that may cause symptoms in patients with weak immune systems) or kidney disease.
- tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking emtricitabine, call your doctor. Tell your doctor if you are breast-feeding. You should not breastfeed if you are infected with HIV or if you are taking emtricitabine.
- you should know that your body fat may increase or move to different areas of your body such as your breasts and upper back.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take more than one dose of emtricitabine in one day and do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Emtricitabine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- headache
- diarrhea
- change in skin color, especially on the palms of the hands or the soles of the feet
- indigestion
- joint pain
- unusual dreams
- depression
- trouble falling asleep or staying asleep
- numbness, burning, or tingling in the hands, arms, feet, or legs
- runny nose
Some side effects can be serious. If you experience any of the following symptoms, or those mentioned in the IMPORTANT WARNING section, call your doctor immediately:
- fever, chills, sore throat, cough, or other signs of infection
- rash
Emtricitabine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store the capsules at room temperature and away from excess heat and moisture (not in the bathroom). Store the solution in the refrigerator, but do not freeze it. If you prefer not to refrigerate the solution, you may store it at room temperature for up to 3 months. Throw away any medication that is outdated or no longer needed, and any unused solution that has not been refrigerated after 3 months. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
Brand name(s) of combination products:
|
|
Ask Our Patient Community about Emtricitabine |
||
|
|
||
|
|
||